PharmAust CEO's sayanora triggers stock plunge
Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of its CEO, Dr. Michael Thurn.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
CMO | Ann: Notice of Change in Officer's Interests | 08/03/24 | 0 | 43 | |||
|
|||||||
CMO | Ann: Notice of Change in Officer's Interests | 08/03/24 | 0 | 53 | |||
|
|||||||
CMO | Ann: Notice of Change in Officer's Interests | 08/03/24 | 0 | 40 | |||
|
|||||||
CMO | Ann: Notice of Change in Director's Interests | 08/03/24 | 0 | 43 | |||
|
|||||||
CMO | Ann: Half Year Result to 31 December 2023 | 21/02/24 | 0 | 54 | |||
|
|||||||
CMO | Ann: Guidance Update | 18/01/24 | 0 | 71 | |||
|
|||||||
CMO | Ann: 2023 Annual Meeting results | 10/11/23 | 0 | 80 | |||
|
|||||||
CMO | Ann: Chair's Address and Presentations to 2023 Annual Meeting | 10/11/23 | 0 | 97 | |||
|
See All Discussions